Comparative Effectiveness of Denosumab versus Alendronate Among Postmenopausal Women with Osteoporosis in the US Medicare Program

被引：0
|
作者：
Curtis, Jeffrey [1 ]
Arora, Tarun [2 ]
Liu, Ye [1 ]
Lin, Tzu-Chieh [3 ]
Spangler, Leslie [3 ]
Brunetti, Vanessa C. [3 ]
Stad, Robert K. [3 ]
McDermott, Michele [3 ]
Bradbury, Brian D. [3 ]
Kim, Min [3 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Fdn Adv Sci Technol Educ & Res, Birmingham, AL USA
[3] Amgen Inc, Thousand Oaks, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2008
引用
收藏
页码：3979 / 3981
页数：3
相关论文
共 50 条
  • [21] COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS ALENDRONATE FOR POSTMENOPAUSAL OSTEOPOROSIS IN SOUTH KOREA
    Bae, G.
    Kwon, H.
    An, J.
    Park, J.
    VALUE IN HEALTH, 2018, 21 : S82 - S82
  • [22] The effectiveness of alendronate in the prevention of postmenopausal osteoporosis
    Hepgüler, S
    Toprak, H
    Capaci, K
    Oztürk, C
    Aksit, R
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S183 - S183
  • [23] COMPARATIVE EFFECTIVENESS OF OSTEOPOROSIS (OP) THERAPIES AMONG A POPULATION OF POSTMENOPAUSAL (PM) WOMEN IN THE UNITED STATES (US)
    Kim, M.
    Mcgrath, L.
    Pritchard, D.
    Samai, P.
    Lin, T.
    Stad, R.
    Spangler, L.
    Mcdermott, M.
    Bradbury, B.
    Brookhart, M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S304 - S305
  • [24] The Effectiveness of Denosumab in the Treatment of Postmenopausal Osteoporosis
    Aras, Berke
    Kuzu, Omer
    ERCIYES MEDICAL JOURNAL, 2022, 44 (03) : 312 - 317
  • [25] Comparative Effectiveness of Osteoporosis (OP) Therapies Among a Population of Postmenopausal (PM) Women in the United States (US)
    Kim, Min
    McGrath, Leah J.
    Pritchard, David
    Samai, Peter
    Lin, Jay
    Stad, Robert Kees
    Spangler, Leslie
    McDermott, Michele
    Bradbury, Brian D.
    Brookhart, M. Alan
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1169 - 1170
  • [26] Infection among Denosumab and Alendronate Users for Osteoporosis
    Liu, Jiannong
    Guo, Haifeng
    Niewan, Kimberly
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 245 - 245
  • [27] DENOSUMAB COMPARED WITH ALENDRONATE IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN PREVIOUSLY TREATED WITH ALENDRONATE
    Bernad, M.
    Garces, M.
    Martin Mola, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 768 - 768
  • [28] COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH GENERIC ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    Hiligsmann, Mickael
    Reginster, Jean-Yves
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 112 - 113
  • [29] COST-EFFECTIVENESS OF DENOSUMAB COMPARED WITH GENERIC ALENDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROTIC WOMEN
    Hiligsmann, M.
    Reginster, J. Y.
    VALUE IN HEALTH, 2010, 13 (07) : A309 - A310
  • [30] The effectiveness and tolerability of alendronate in case of postmenopausal osteoporosis
    Hepgüler, S
    Ozvurmaz, S
    Oztürk, C
    Capaci, K
    Aksit, R
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S183 - S183
12345